JP2011517548A5 - - Google Patents

Download PDF

Info

Publication number
JP2011517548A5
JP2011517548A5 JP2010515209A JP2010515209A JP2011517548A5 JP 2011517548 A5 JP2011517548 A5 JP 2011517548A5 JP 2010515209 A JP2010515209 A JP 2010515209A JP 2010515209 A JP2010515209 A JP 2010515209A JP 2011517548 A5 JP2011517548 A5 JP 2011517548A5
Authority
JP
Japan
Prior art keywords
antibody
mcp
variable region
chain variable
light chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010515209A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011517548A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/068696 external-priority patent/WO2009006359A2/en
Publication of JP2011517548A publication Critical patent/JP2011517548A/ja
Publication of JP2011517548A5 publication Critical patent/JP2011517548A5/ja
Pending legal-status Critical Current

Links

JP2010515209A 2007-06-29 2008-06-30 抗ｍｃｐ−１抗体、組成物、方法及び使用 Pending JP2011517548A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94698807P 2007-06-29 2007-06-29
US60/946,988 2007-06-29
PCT/US2008/068696 WO2009006359A2 (en) 2007-06-29 2008-06-30 Anti- mcp-1 antibodies, compositions, methods and uses

Publications (2)

Publication Number Publication Date
JP2011517548A JP2011517548A (ja) 2011-06-16
JP2011517548A5 true JP2011517548A5 (enExample) 2011-08-04

Family

ID=40158715

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010515209A Pending JP2011517548A (ja) 2007-06-29 2008-06-30 抗ｍｃｐ−１抗体、組成物、方法及び使用

Country Status (8)

Country Link
US (1) US20100254992A1 (enExample)
EP (1) EP2170387A4 (enExample)
JP (1) JP2011517548A (enExample)
CN (1) CN101827610A (enExample)
AU (1) AU2008269954A1 (enExample)
CA (1) CA2692392A1 (enExample)
IL (1) IL202996A0 (enExample)
WO (1) WO2009006359A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2686008A1 (en) * 2011-03-15 2014-01-22 INSERM - Institut National de la Santé et de la Recherche Médicale Compositions and methods for inhibiting tumor development caused by chemotherapy induced senescence
CN110072883A (zh) 2016-09-28 2019-07-30 科巴公司 治疗性mots-c相关的肽
EP3773627A1 (en) 2018-03-27 2021-02-17 Cohbar Inc. Peptide-containing formulations
US11739142B2 (en) 2019-12-18 2023-08-29 Hoffmann-La Roche Inc. Bispecific anti-CCL2 antibodies
CN112358547A (zh) * 2020-09-30 2021-02-12 浙江大学 抗人cxcl-2单克隆抗体3-d3及其编码基因和应用
AU2022295067A1 (en) * 2021-06-18 2023-12-21 F. Hoffmann-La Roche Ag Bispecific anti-ccl2 antibodies
CN118620076B (zh) * 2024-07-03 2024-12-17 武汉爱博泰克生物科技有限公司 用于检测鼠单核细胞趋化蛋白1的抗体和抗体对及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510264A (en) * 1993-09-28 1996-04-23 Insight Biotech Inc. Antibodies which bind meningitis related homologous antigenic sequences
US6696248B1 (en) * 1995-08-18 2004-02-24 Morphosys Ag Protein/(poly)peptide libraries
JPH0967399A (ja) * 1995-08-30 1997-03-11 Mitsui Toatsu Chem Inc 抗ｍｃｐ−１ヒトモノクローナル抗体
PL209786B1 (pl) * 1999-01-15 2011-10-31 Genentech Inc Przeciwciało zawierające wariant regionu Fc ludzkiej IgG1, przeciwciało wiążące czynnik wzrostu śródbłonka naczyń oraz immunoadhezyna
GB0016138D0 (en) * 2000-06-30 2000-08-23 Novartis Ag Organic compounds
RU2339647C2 (ru) * 2002-08-19 2008-11-27 Астразенека Аб Антитела против моноцитарного хемоаттрактантного белка-1 (мср-1) и их применение
CA2507080C (en) * 2002-11-27 2015-01-06 Biogen Idec Ma Inc. Humanized antibodies against monocyte chemotactic proteins
WO2006125201A2 (en) * 2005-05-19 2006-11-23 Centocor, Inc. Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
US8114964B2 (en) * 2005-05-19 2012-02-14 Centocor, Inc. Anti-MCP-1 antibodies, compositions, methods and uses
PE20061444A1 (es) * 2005-05-19 2007-01-15 Centocor Inc Anticuerpo anti-mcp-1, composiciones, metodos y usos

Similar Documents

Publication Publication Date Title
HRP20140982T1 (hr) Ljudska anti-il-23 antitijela, pripravci, postupci i upotrebe
JP2007508011A5 (enExample)
JP2005512522A5 (enExample)
JP2011517548A5 (enExample)
CA2609349A1 (en) Anti-mcp-1 antibodies, compositions, methods and uses
ME02185B (me) Anti-il-6 antitela, preparati, postupci pripreme i upotrebe
ES2892954T3 (es) Derivados fluorados del ácido 3-(2-oxo-3-(3-(5,6,7,8-tetrahidro-1,8-naftiridin-2-il)propil)imidazolidin-1-il)propanoico y usos de los mismos
ES2327830T3 (es) Anticuerpos monoclonales humanos anti-interleuquina-5 y metodos y composiciones que los contienen.
ES2759530T3 (es) Composición farmacéutica que contiene derivados de glutarimida, y la aplicación de la misma para el tratamiento de enfermedades eosinofílicas
JP2008525477A5 (enExample)
CA2418962A1 (en) Anti-dual integrin antibodies, compositions, methods and uses
CA2419205A1 (en) Anti-tnf antibodies, compositions, methods and uses
JP5264739B2 (ja) ポリグルタミン伸長関連疾患を治療するための塩素グアナベンズ誘導体の使用
JP2008523842A5 (enExample)
US9862721B2 (en) Tetrahydrocarboline derivative
JP2010534664A5 (enExample)
KR20120105429A (ko) 염증 치료 방법
US11013740B2 (en) Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
JP2025108536A (ja) 新規な分子
CN102666587A (zh) 用于治疗肌营养不良的方法
CN106459021A (zh) 用于治疗神经退行性疾病的组合物和方法
KR20120041071A (ko) Ｈｉｆ-1 활성을 저해하는 아릴옥시페녹시아세틸계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
WO2022105665A1 (zh) 一种预防、治疗疼痛、炎症的化合物及其应用
KR20200083996A (ko) 인터류킨-17(il-17)을 사용하여 건병증을 치료하는 방법
WO2015062555A1 (zh) 具有更高蛋白激酶g抑制活性的化合物及其制备方法